GoodRx Holdings, Inc. (GDRX) stock
Close on Nov 13, 2026Market cap $1.21BP/E 89.0Yield –
GoodRx Holdings, Inc. saw revenue fall 1.8% to $785.23M over the twelve months to Jun 30, 2026. Operating income fell 15.6% to $74.94M, moving the operating margin from 11.1% to 9.5%. Free cash flow was $197.09M, up 4.0% from a year earlier. At the latest close the market valued the company at $1.21B, 89.0 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.21B
- P/E ratio
- 89.0
- Price to sales
- 1.55
- Price to book
- 1.88
- Dividend yield
- –
- Free cash flow yield
- 16.23%
Fundamentals
- Revenue
- $785.23M
- Net income
- $16.25M
- EPS, diluted
- $0.04
- Free cash flow
- $197.09M
- Book value per share
- $1.86
- Diluted shares
- 348M
Trading
- Next earnings
- Q3 FY2026, expected soon
- Previous close
- $3.51
- Open
- $3.56
- Day's range
- $3.50 – $3.61
- Volume
- 788,259
- Average volume (20 days)
- 1,183,541
- Beta (5 years)
- 1.71
- 52-week range
- $1.77 – $3.89
- RSI (14 days)
- 52.0
- Volatility (1 year)
- 56.0%
- Relative volume
- 0.64×
- WACC
- 11.3%
On 2 of our idea lists: Buyback cannibals, Shareholder yield
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | GDRX | S&P 500 | Difference | GDRX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +3.2% | -3.0% | +6.2 pts | ||
| 3 months | -4.3% | -2.8% | −1.5 pts | ||
| Year to date | +31.4% | +11.5% | +19.9 pts | ||
| 1 year | +16.0% | +13.5% | +2.5 pts | ||
| 3 years | -24.4% | +77.7% | −102.1 pts | -8.9% | +21.1% |
| 5 years | -91.5% | +72.6% | −164.1 pts | -38.9% | +11.5% |
Nine years at a glance
Fiscal years 2017 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases GoodRx filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
About GoodRx
Services-Computer Processing & Data Preparation
GoodRx Holdings, Inc. operates a digital healthcare platform that provides consumers with access to discounted prescription medication pricing. The company's primary offerings include prescription transaction services, which deliver digital discount codes for medication purchases outside of standard insurance networks. It also provides healthcare subscription services, such as GoodRx Gold, condition-specific programs, and RxSmartSaver+, alongside a telehealth service and pharmaceutical manufacturer solutions known as Pharma Direct. The company serves individual consumers purchasing prescription drugs and healthcare services, while also collaborating with healthcare providers, retail pharmacies, and pharmaceutical manufacturers.
Company profile, executives and historyGoodRx stock: common questions
What is GoodRx's stock price?
GDRX closed at $3.56 on Nov 13, 2026, up 1.42% on the day. Over the past 52 weeks it traded between $1.77 and $3.89.
What is GoodRx's market cap?
GoodRx was worth $1.21B at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is GDRX's P/E ratio?
GDRX trades at 89.0 times earnings, based on diluted earnings per share of $0.04 over the twelve months to Jun 30, 2026.
How much revenue does GoodRx make?
GoodRx reported revenue of $785.23M for the twelve months to Jun 30, 2026, down 1.8% from a year earlier.
Does GoodRx pay a dividend?
No. GoodRx has not paid a cash dividend over the last twelve months.
When does GoodRx report earnings next?
GoodRx's Q3 FY2026 results are due soon; the company has not yet filed them with the SEC.
How has GDRX stock performed over the past year?
Including dividends, GDRX returned +16.0% over the past year, against +13.5% for the S&P 500.
How many GDRX shares are sold short?
4M shares were sold short at the latest FINRA report, 1.93% of the float, or 3.0 days of average trading volume.
Who are GoodRx's competitors?
Companies most similar to GoodRx by business, industry and size include HNGE, NRDS, SSTK, CARG, CARS.
See a number that looks wrong?